Obstruction of the respiratory pathways, its evaluation by methods of functional examination of the lungs and development in patients with cystic fibrosis
- PMID: 527420
Obstruction of the respiratory pathways, its evaluation by methods of functional examination of the lungs and development in patients with cystic fibrosis
Abstract
In 28 patients with cystic fibrosis aged 5--24 years the values of maximum expiratory flow rates (Vmax) at lower volume levels were assessed, as well as the "specific" conductance of the respiratory pathways (Gaw/TGV), the vital capacity (VC), total lung capacity (TLC), residual volume (RV), functional residual capacity (FRC), RV/TLC and FRC/TLC ratios and the one-second forced expiration of the vital capacity (FEV1) to evaluate obstruction of the respiratory pathways. Most markedly and most frequently abnormal were the values of Vmax, RV and of the RV/TLC ratio. These findings revealed that in almost all patients with CF there was already during the initial examination an obstruction of the peripheral respiratory pathways and hyperinflation of the lungs. During repeated measurement of the above values of lung function in 15 patients with cystic fibrosis during a period of 1--5 years when the patients increased in height by 10 cm on average, the above values did not deteriorate on average. There was, however, an individual variability of the investigated values during this period. The comprehensive treatment provided in our country prevented in patients with CF a deterioration of obstruction of the respiratory pathways during the period of investigation.
Similar articles
-
Lung function abnormalities in cystic fibrosis and changes during growth.Bull Eur Physiopathol Respir. 1979 Jul-Aug;15(4):575-92. Bull Eur Physiopathol Respir. 1979. PMID: 497487
-
Timing and driving components of the breathing strategy in children with cystic fibrosis during exercise.Pediatr Pulmonol. 2005 Nov;40(5):449-56. doi: 10.1002/ppul.20266. Pediatr Pulmonol. 2005. PMID: 16163725
-
Restrictive impairment in patients with asthma.Respir Med. 2007 Feb;101(2):272-6. doi: 10.1016/j.rmed.2006.05.008. Epub 2006 Jun 22. Respir Med. 2007. PMID: 16797172
-
On the causes of lung hyperinflation during bronchoconstriction.Eur Respir J. 1997 Feb;10(2):468-75. doi: 10.1183/09031936.97.10020468. Eur Respir J. 1997. PMID: 9042651 Review.
-
Determinants of respiratory pump function in patients with cystic fibrosis.Paediatr Respir Rev. 2015 Jan;16(1):75-9. doi: 10.1016/j.prrv.2014.01.001. Epub 2014 Jan 28. Paediatr Respir Rev. 2015. PMID: 24661942 Review.
MeSH terms
LinkOut - more resources
Medical